These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

81 related articles for article (PubMed ID: 23472551)

  • 1. How data can help reduce vascular access events.
    Swails-Climer M
    Nephrol News Issues; 2012 Nov; 26(12):30-2. PubMed ID: 23472551
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of a vascular access surveillance program on service provision and access thrombosis.
    Jiang S; Stewart G; Barnes E; Jardine M; Razavian M; Gallagher M
    Semin Dial; 2013; 26(3):361-5. PubMed ID: 22994648
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Vascular access management: ongoing challenges and strategies for success.
    Peters V; Crooks P; Rutkowski M; Cairoli O
    Nephrol News Issues; 2014 Mar; 28(3):26, 28, 30-3. PubMed ID: 24720013
    [No Abstract]   [Full Text] [Related]  

  • 4. [Analysis of the survival of permanent vascular access ports].
    Rodríguez JA; Ferrer E; Olmos A; Codina S; Borrellas J; Piera L
    Nefrologia; 2001; 21(3):260-73. PubMed ID: 11471307
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Role of access surveillance and preemptive intervention.
    Work J
    Semin Vasc Surg; 2011 Jun; 24(2):137-42. PubMed ID: 21889103
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Impact of a quality improvement programme based on vascular access flow monitoring on costs, access occlusion and access failure.
    Wijnen E; Planken N; Keuter X; Kooman JP; Tordoir JH; de Haan MW; Leunissen KM; van der Sande F
    Nephrol Dial Transplant; 2006 Dec; 21(12):3514-9. PubMed ID: 16921189
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Outcome of the use of stent grafts to salvage failed arteriovenous accesses.
    Webb KM; Cull DL; Carsten CG; Johnson BL; Taylor SM
    Ann Vasc Surg; 2010 Jan; 24(1):34-8. PubMed ID: 19765947
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Importance of Context to Interpretation of Dialysis Access Patterns: Insights from the UK Renal Registry Data Set.
    Hole B
    Perit Dial Int; 2019; 39(1):19-24. PubMed ID: 30692233
    [No Abstract]   [Full Text] [Related]  

  • 9. Failure to follow K/DOQI guidelines decreases effectiveness of access flow surveillance.
    Levine M
    Kidney Int; 2004 Jan; 65(1):338-9; author reply 339. PubMed ID: 14675072
    [No Abstract]   [Full Text] [Related]  

  • 10. A challenge for nephrologists--increasing fistula maturation rates, reducing fistula maturation time, and decreasing dialysis catheter prevalence in the United States.
    Levine MI
    Semin Dial; 2008; 21(3):280-4. PubMed ID: 18533969
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Vascular dialysis access flow measurement: early intervention through early detection.
    Miguel SS; Chow J
    J Ren Care; 2009 Dec; 35(4):185-91. PubMed ID: 19909411
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evaluation of primary failure in native AV-fistulae (early fistula failure).
    Ohira S; Kon T; Imura T
    Hemodial Int; 2006 Apr; 10(2):173-9. PubMed ID: 16623671
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Improving access patency: pre-end-stage renal disease strategies.
    Schwab SJ
    J Am Soc Nephrol; 1998 Dec; 9(12 Suppl):S124-9. PubMed ID: 11443759
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Surveillance for infections and other adverse events in dialysis patients in southern Gran Canaria.
    Quori A; Baamonde-Laborda E; García-Cantón C; Lago-Alonso MM; Toledo-González A; Monzón-Jiménez E; Jiménez-Díaz D; Checa-de-Andrés M; Molina-Cabrillana J
    Nefrologia; 2011; 31(4):457-63. PubMed ID: 21623394
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Vascular access for hemodialysis: thrills and thrombosis.
    Gilpin V; Nichols WK
    J Vasc Nurs; 2010 Jun; 28(2):78-83. PubMed ID: 20494299
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Automated intravascular access pressure surveillance reduces thrombosis rates.
    Zasuwa G; Frinak S; Besarab A; Peterson E; Yee J
    Semin Dial; 2010; 23(5):527-35. PubMed ID: 20723160
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Identifying vascular access complications among ESRD patients in Europe. A prospective, multicenter study.
    Elseviers MM; Van Waeleghem JP;
    Nephrol News Issues; 2003 Jul; 17(8):61-4, 66-8, 99. PubMed ID: 12882114
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Association between vascular access failure and the use of specific drugs: the Dialysis Outcomes and Practice Patterns Study (DOPPS).
    Saran R; Dykstra DM; Wolfe RA; Gillespie B; Held PJ; Young EW;
    Am J Kidney Dis; 2002 Dec; 40(6):1255-63. PubMed ID: 12460045
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Equivalent secondary patency rates of upper extremity Vectra Vascular Access Grafts and transposed brachial-basilic fistulas with aggressive access surveillance and endovascular treatment.
    Kakkos SK; Andrzejewski T; Haddad JA; Haddad GK; Reddy DJ; Nypaver TJ; Scully MM; Schmid DL
    J Vasc Surg; 2008 Feb; 47(2):407-14. PubMed ID: 18155874
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Noninvasive methods to identify early vascular access dysfunction.
    Soule JL; Henry ML
    Semin Vasc Surg; 2007 Sep; 20(3):164-6. PubMed ID: 17884617
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.